Azenta Life Sciences Partners with PRECEDE Foundation to Advance Early Detection of Pancreatic Cancer

BURLINGTON, Mass., Nov. 4, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced a strategic partnership with the PRECEDE Foundation, an international, multi-institutional collaborative focused on early detection and prevention of pancreatic cancer. Azenta will provide secure storage of study samples in its biorepository and streamline logistics, enabling PRECEDE researchers to focus on advancing diagnostics and patient survival.

Read more at prnewswire.com